The risk of using antiplatelet and/or anticoagulant treatment for hemorrhagic adverse events during EUS-guided biliary drainage. Chiang HC. Gastrointest Endosc 2023;97:1170.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chiang HC. The risk of using antiplatelet and/or anticoagulant treatment for hemorrhagic adverse events during EUS-guided biliary drainage. Gastrointest Endosc 2023;97:1170.
PMID: 37208044